Research reportWhich patients receive antidepressants? A `real world' telephone study
Introduction
Antidepressants have been used for over three decades and their clinical efficacy and indications are largely consensual. There remain a number of troublesome questions, however, regarding their actual use outside the specific setting of clinical trials. The undertreatment of clinically diagnosed depressed patients has been repeatedly reported (Isacsson et al., 1992, Wells et al., 1994). Recent concerns also appeared after newer antidepressants such as specific serotonin reuptake inhibitors (SSRI) were marketed: firstly, a number of pharmacoeconomic papers have dealt with increasing health costs due to the higher price of the more recent drugs, although it is increasingly recognized that this situation is overall balanced by their better acceptability, which might lower the overall health costs associated with depression (Montgomery and Kasper, 1995, Simon et al., 1995a). Secondly, there has been a wide debate in the lay as well as in the academic press over personality changes and extratherapeutic or recreational use of these drugs (Kramer, 1993, Barondes, 1994, Medawar, 1994, Freeman, 1994, Kaplan, 1994, Walder, 1994, Manolis, 1995).
The classical, `gold standard', controlled clinical trials are poorly, if at all, able to deal with such problems, which are better addressed by epidemiological, pharmacoeconomic or `real world' studies, respectively. The advantages of the latter are obvious in terms of assessment of actual patterns of prescription (Simon et al., 1995b).
The present work was undertaken to provide real world data regarding the use of antidepressant medications, with special emphasis on current diagnosis, treatment history, and overall appropriateness of the prescription with respect to current guidelines, in a representative sample of the French population. This sample, which will be described in more detail in the methods section, was selected on the basis of antidepressant use, whatever the diagnosis, which overcomes the bias induced by patient or physician report. The diagnosis was established retrospectively by the means of a structured telephone interview.
Section snippets
The SOFRES database.
SOFRES, a poll company, routinely scrutinizes a sample group of the French population, comprising over 40 000 individuals in 20 000 households. This sample group has been shown to be representative of the French population as a whole with respect to age, social status, size of the household, and living area. It is renewed by a quarter each year.
Step 1. A questionnaire aimed at identifying antidepressant consumption at the time of the study was sent to all households, out of which 15 800
Overall prescription pattern
Eight hundred and ninety-six individuals (2.75%) reported to be on antidepressant treatment at the time of the study. Extrapolation of this figure to the whole population suggests that 1 094 300 persons received antidepressive drugs (ADD) at that time in France.
Antidepressant users were more likely to live in the south east of France, and less likely in the north and east as well as in a rural area (P<0.05). The sex ratio (M/F) was 27/73 as opposed to 48.1/51.9 in non users (P<0.05). People
Discussion
There is little doubt that actual drug use seldom strictly complies with ad hoc clinical guidelines. This situation stresses the need for investigation tools able to account for such discrepancies. Recently `real world studies' have turned out to be of special interest in this special context and their advantages have been underscored (Simon et al., 1995b). The present study attempted such an investigation, with the aim of assessing to what extent antidepressants prescription conforms to
Conclusion
Overall, the present study confirms previous doubts regarding the appropriate use of antidepressants. The high rate of concomitant prescription of benzodiazepines, and the fact that 22% of users appear not to pertain to any psychiatric diagnosis appear especially troublesome. In this context, the prescription of fluoxetine appears to be significantly more consistent with acknowledged guidelines than that of other antidepressants. In spite of these findings, it must also be stressed that the
References (19)
- et al.
The Mini International Neuropsychiatric Interview (MINI) a short diagnostic structured interview: reliability and validity according to the CIDI
Am. J. Psychiatry
(1997) - et al.
Outpatient utilization of antidepressants: a prescription database analysis
J. Affect. Disord.
(1993) - et al.
Cost-effectiveness comparisons using `real world' randomized trials: the case of new antidepressant drugs
J. Clin. Epidemiol.
(1995) Epidemiology of depression
Psychopharmacology
(1992)Thinking about Prozac
Science
(1994)Listening to Prozac - Correspondence
Nature
(1994)- et al.
Low level of antidepressant prescription for people who later commit suicide: 15 years of experience from a population-based drug database in Sweden
Acta Psychiatr. Scand.
(1992) Listening to Prozac - Correspondence
Nature
(1994)- Kramer, P.D. (1993). Listening to Prozac. A psychiatrist explores antidepressant drugs and the remaking of the self....
Cited by (21)
Adjustment to antidepressant utilization rates to account for depression in remission
2004, Comprehensive PsychiatryPsychotropic prescription in non-psychiatric hospital settings
2002, European PsychiatryAntidepressants plus benzodiazepines for adults with major depression
2019, Cochrane Database of Systematic Reviews